The Liver Summit (TLS 2026) is a one-day, high-impact CME conference bringing together leaders in hepatology, metabolic medicine, obesity care, primary care, and allied health. Designed to deliver practical, patient-centered, and clinically actionable education, TLS 2026 explores the rapidly evolving intersection of liver disease and metabolic health, one of the fastest advancing areas in modern medicine.

The multidisciplinary program features nationally and internationally recognized experts covering obesity medicine, GLP-1 therapies, diabetes and cardiovascular risk reduction, steatotic liver disease (MASLD and MetALD), alcohol-related liver disease, liver transplantation, hepatobiliary oncology, viral hepatitis, artificial intelligence in clinical practice, and emerging therapeutic pipelines. Interactive panel discussions, case-based “How I Treat” sessions, and a patient-perspective presentation provide practical insights that attendees can immediately apply to clinical practice.

Healthcare professionals may attend in person or via livestream, with both formats eligible for 6 AMA PRA Category 1 Credits™. Complimentary registration is available for all healthcare professionals. The program also includes an industry-supported educational symposium, a dedicated Product Theater, networking opportunities with faculty and industry partners, and a closing reception designed to foster multidisciplinary collaboration.

Whether you are a physician, advanced practice provider, nurse, pharmacist, dietitian, researcher, or allied healthcare professional, TLS 2026 offers a comprehensive, evidence-based update on the latest advances in liver and metabolic health while providing practical strategies to improve patient care.

Event Directors

Thomas G. Cotter

MD, MS — President

General and transplant hepatologist and obesity medicine specialist who founded Texas Liver Care in 2025 to advance education, outreach, and innovation in liver and metabolic health

Sumeet Asrani

Event Participants

Mazen Noureddin

Naim Alkhouri

Juan Pablo Arab

Michael Charlton

Tonia Vinton

Mack Mitchell

Jeremy Louissaint

Ashwini Mehta

Thomas Kerr

Scott Carlson

Ranjeeta Bahirwani

Mohammad Qasim Khan

Mazen Iskandar

Fabrizzio Delgado

Craig Rosenstengle

Ahmad Anouti

Patient Advocacy Director

Biliary atresia liver transplant recipient, physician, researcher, and patient advocate. Manages board communications, governance compliance, and official records, providing unique patient-centered perspectives.

Event Agenda

Saturday, September 26, 2026

7:45 AM - 8:30 AMBreakfast and Registration - Delta Marriott Foyer

Session 1 - Integrating Metabolic Health in Liver Care (Delta Marriott Conference Room)Moderator: Sumeet Asrani, MD MSc

8:30 AM - 8:55 AMWeight Management in Liver Disease: Diet, Activity, and Obesity PharmacotherapyTonia Vinton, MD

9:55 AM - 9:20 AMEndobariatrics & Bariatric Surgery in the GLP-1 Agonist EraMazen Iskander, MD

9:20 AM - 9:45 AMPractical Management Strategies for Diabetes, Hypertension, and Cardiovascular Risk ReductionScott Carlson, MD

9:45 - 10:10 AM

Metabolic Health After Transplant: Preventing Weight Gain, Diabetes, and Cardiovascular DiseaseMohammad Qasim Khan, MD

10:10 - 10:30 AMPanel Discussion & Q&A

10:30 AM - 10:40 AMCoffee Break  - Foyer

10:40 AM - 11:00 PMLiving the Journey: A Patient's Perspective on Liver DiseaseAhmad Anouti, MD

11:00 AM - 11:30 AMCoffee and Visit Exhibits - Delta Marriott Foyer

11:30 AM - 12:15 PMDelta Marriott Conference RoomIndustry-Supported Educational Symposium (Non-CME)Ashwini Mehta, DO Industry-Sponsored EventSponsored by Madrigal Pharmaceuticals

12:15 PM - 12:45 PMLunch and Visit Exhibits - Delta Marriott Foyer

 

Session 2 - Steatotic Liver Disease - The Clinical Spectrum & Future DirectionsModerator: Mack Mitchell, MD

12:45 PM - 1:10 PMMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Clinical Impact & Evolving ConceptsNaim Alkhouri, MD

1:10 PM - 1:35 PMMetabolic Dysfunction-Associated Alcohol-Related Liver Disease (MetALD): Defining the OverlapJuan Pablo Arab MD

1:35 PM - 2:00 PMAlcohol Use Disorder and Disordred Eating in Liver Disease: Clinical Management StrategiesFabrizzio Delgado, MD

2:00 PM - 2:25 PMSteatotic Liver Disease Drug Pipeline: Current Trials and Future HorizonsMichael Charlton, MBBS

2:25 PM - 2:50 PM

How I Treat MASLD and MetALD: A Practical, Case-Based Approach

2:50 PM - 3:10 PMPanel Discussion & Q&A

3:10 PM - 3:20 PMBreak and Visit Exhibits - Foyer

Session 3 - General Hepatology Updates

Moderator: Mohammad Qasim Khan, MD

3:20 PM - 3:40 PMPrimary Biliary Cholangitis and Primary Sclerosing Cholangitis: Diagnosis and Treatment UpdatesAshwini Mehta, DO

3:40 PM - 4:00 PMHepatocellular Carcinoma and Cholangiocarcinoma: Advances in Diagnosis and ManagementCraig Rosenstengle, MD

4:00 PM - 4:20 PMArtificial Intelligence in Liver CareJeremy Louissaint, MD

4:20 PM - 4:40 PMPreventing Cirrhosis Complications: From Anticoagulation to Beta BlockersRanjeeta Bahirwani, MD 4:40 PM - 5:00 PMViral Hepatitis in 2026: Practical Updates in Screening, HBV Management, and Cure PathwaysThomas Kerr, MD

Close at 5:00 PMClosing Remarks and Networking Reception

Event Gallery

Details

Venue

Tickets

The numbers below include tickets for this event already in your cart. Clicking "Get Tickets" will allow you to edit any existing attendee information as well as change ticket quantities.
Industry, In-Person Only
$ 80.00
Unlimited
Physician (MD or DO), In-Person
$ 0.00
Unlimited
Advanced Practice Provider (PA or NP), In-Person
$ 0.00
Unlimited
Pharmacist, In-Person
$ 0.00
Unlimited
Nurse or other healthcare provider, In-Person
$ 0.00
Unlimited
Livestream / Teleconference (Healthcare professionals only)
$ 0.00
Unlimited
Trainee (Fellow/Resident/Medical Student), In-Person
$ 0.00
Unlimited
Quantity: 0
Total: $ 0.00